You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
28 April 2020
In response to the COVID-19 pandemic, the European Council has adopted the European Commission’s proposal to postpone by one year the date of application of the new Medical Devices Regulation, regulatory agencies around the world have stepped up global collaboration, and the US has taken action on h...
21 April 2020
In response to the COVID-19 pandemic, France has warned people to stop taking certain food supplements if they have COVID-19, the UK has issued advice on the use of ibuprofen and COVID-19, and the US has authorised the first diagnostic test for COVID-19 with at-home sample collection.
2 April 2020
The US Food and Drug Administration (FDA) has asked manufacturers to withdraw all prescription and OTC medicines containing ranitidine from the market immediately.
20 March 2020
The World Health Organization (WHO) has responded to reports that taking ibuprofen could worsen symptoms of the COVID-19 coronavirus.
17 December 2019
Belgium is banning combination cough and cold medicines, France is seeking to ensure safe use of vasoconstrictors, the US Senate has passed key OTC legislation, and the new commissioner of the US Food and Drug Administration (FDA) has been confirmed.
4 November 2019
President Donald Trump has nominated cancer specialist Stephen Hahn to be commissioner of the US Food and Drug Administration (FDA).
24 October 2019
The US Food and Drug Administration (FDA) has updated its approach to homeopathic products, Australia’s Therapeutic Goods Administration (TGA) is consulting on a proposal affecting supports supplements, and the UK's Medicines and Healthcare products Regulatory Agency (MHRA) has announced a promotion...
27 September 2019
Regulatory agencies around the world are taking action on medicines containing ranitidine after tests showed some contain "low levels" of a probable human carcinogen called N-nitrosodimethylamine (NDMA).
23 September 2019
Advisers to the US Food and Drug Administration (FDA) have recommended that GlaxoSmithKline (GSK) Consumer Healthcare's nicotine oral spray can be marketed as an OTC product.
20 August 2019
GlaxoSmithKline (GSK) Consumer Healthcare is seeking to extend its range of OTC nicotine-replacement therapy (NRT) products in the US with a nicotine oral spray.